Search research articles
Contact Us
Filters
Showing results (201-210 of 251) with videos related to
Page
of 26
Sort By:
Breast Cancer Research and Treatment
|
May 24, 2023
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer
M K Bos, S W Lam, G Motta, et al.
Metabolism: Clinical and Experimental
|
July 6, 2012
Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: the CODAM study
Nick Wlazlo, Marleen M J van Greevenbroek, Isabel Ferreira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2007
HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study
Maurice P H M Jansen, Anieta M Sieuwerts, Maxime P Look, et al.
Annals of Translational Medicine
|
September 17, 2021
Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesis
Jonathan Spoor, Ben M Eyck, Peggy N Atmodimedjo, et al.
Molecular Oncology
|
February 7, 2017
Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions
Lisanne F van Dessel, Nick Beije, Jean C A Helmijr, et al.
Breast Cancer Research and Treatment
|
February 27, 2008
TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer
Danielle Meijer, Maurice P H M Jansen, Maxime P Look, et al.
BMC Cancer
|
February 13, 2022
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer
Silvia R Vitale, Kirsten Ruigrok-Ritstier, A Mieke Timmermans, et al.
Breast Cancer Research and Treatment
|
March 23, 2010
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
E A Reijm, M P H M Jansen, K Ruigrok-Ritstier, et al.
Molecular Oncology
|
December 6, 2018
High-throughput isolation of circulating tumor DNA: a comparison of automated platforms
Lisanne F van Dessel, Silvia R Vitale, Jean C A Helmijr, et al.
The British Journal of Surgery
|
April 12, 2026
Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naïve colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohort
Lissa Wullaert, Lotte van Leeuwen, Vanja de Weerd, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 251) with videos related to
Sort By:
Page
of 26
Breast Cancer Research and Treatment
|
May 24, 2023
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer
M K Bos, S W Lam, G Motta, et al.
Metabolism: Clinical and Experimental
|
July 6, 2012
Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: the CODAM study
Nick Wlazlo, Marleen M J van Greevenbroek, Isabel Ferreira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2007
HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study
Maurice P H M Jansen, Anieta M Sieuwerts, Maxime P Look, et al.
Annals of Translational Medicine
|
September 17, 2021
Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesis
Jonathan Spoor, Ben M Eyck, Peggy N Atmodimedjo, et al.
Molecular Oncology
|
February 7, 2017
Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions
Lisanne F van Dessel, Nick Beije, Jean C A Helmijr, et al.
Breast Cancer Research and Treatment
|
February 27, 2008
TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer
Danielle Meijer, Maurice P H M Jansen, Maxime P Look, et al.
BMC Cancer
|
February 13, 2022
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer
Silvia R Vitale, Kirsten Ruigrok-Ritstier, A Mieke Timmermans, et al.
Breast Cancer Research and Treatment
|
March 23, 2010
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
E A Reijm, M P H M Jansen, K Ruigrok-Ritstier, et al.
Molecular Oncology
|
December 6, 2018
High-throughput isolation of circulating tumor DNA: a comparison of automated platforms
Lisanne F van Dessel, Silvia R Vitale, Jean C A Helmijr, et al.
The British Journal of Surgery
|
April 12, 2026
Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naïve colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohort
Lissa Wullaert, Lotte van Leeuwen, Vanja de Weerd, et al.
Page
of 26